The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -8.04% | -4.49% | 10.8% | 14.7% | 7.94% | 4.75% | 19.65% | 20.4% | 13.41% | 12.86% | 14.71% |
| Category returns | -7.54% | -3.42% | 10.54% | 13.4% | 8.01% | 3.9% | 18.22% | 18.48% | 12.78% | 13.01% | N/A |
| Absolute returns | -8.04% | -4.49% | 10.8% | 14.7% | 7.94% | 9.74% | 71.4% | 110.28% | 87.71% | 235.27% | 4066.12% |
| Rank within category | 15/19 | 14/18 | 9/18 | 9/18 | 10/17 | 6/14 | 3/12 | 3/10 | 3/9 | 3/4 | N/A |
| Sector Funds | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | -9.71% | 6.2% | -7.53% | 1.18% | 67.36% | 19.09% | -12.32% | 38.2% | 42.86% | -3.15% | 11.35% |
| Q1 returns | -8.84% | 4.72% | -9.45% | 2.55% | -5.72% | -2.01% | -7.3% | -3.44% | 8.85% | -8.51% | -4.49% |
| Q2 returns | 3.78% | -5.81% | 0.31% | -7.94% | 30.58% | 18.4% | -10.89% | 15.14% | 5.37% | 6.66% | 20.25% |
| Q3 returns | 4.22% | -2.52% | 7.9% | -1.66% | 24.11% | 3.3% | 7.28% | 12.49% | 23.11% | -0.62% | 2.12% |
| Q4 returns | -8.43% | 10.45% | -5.64% | 8.97% | 9.54% | -0.64% | -1.06% | 10.5% | 1.18% | -0.12% | -5.06% |
1% on or before 30D, Nil after 30D
| Alpha | 1.25522 |
| Beta | 0.6634 |
| Sharpe Ratio | 0.316596 |
| Sortino Ratio | 0.669921 |
| R-Squared | 0.3348 |
| Tracking Error | 3.5685 |
| Downside Risk | 17.1244 |
| Std. Deviation (Annualised) | 14.2673 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Regular Plan - Growth | -8.18% | -2.85% | 13.49% | 19.65% | 16.65% | 26.3% | N/A | N/A | 26.16% | 3,501.37 | 2.11 | 0.45 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW | -7.91% | -3.95% | 12% | 16.9% | 9.98% | 20.31% | 16% | 12.88% | 16.36% | 5,870.00 | 1.99 | 0.33 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW Current | -8.04% | -4.49% | 10.8% | 14.7% | 7.94% | 19.65% | 13.41% | 12.86% | 14.71% | 1,429.84 | 2.22 | 0.32 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | -6.65% | -2.37% | 10.95% | 15.8% | 10.86% | 19.1% | 13.11% | N/A | 19.31% | 3,494.44 | 2.04 | 0.30 | Very High |
| ICICI Prudential Healthcare Fund - Growth | -5.27% | -5.77% | 5.31% | 6.11% | 1.04% | 18.9% | 14.21% | N/A | 18.53% | 6,861.20 | 2.08 | 0.30 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | -8.31% | -3.16% | 10.44% | 10.22% | 4.45% | 18.2% | 9.97% | N/A | 16.14% | 99.36 | 2.67 | 0.28 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth | -5.87% | -2.13% | 13.11% | 11.93% | 9.74% | 17.47% | 13.29% | N/A | 20.34% | 3,750.04 | 2.05 | 0.29 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth | -7.92% | -5.04% | 8.82% | 11.15% | 7.84% | 16.89% | 11.54% | N/A | 18.16% | 1,077.52 | 2.29 | 0.27 | Very High |
| Quant Healthcare Fund - Regular Plan - Growth | -7.41% | -1.49% | 10.61% | 18.21% | 9.71% | 16.57% | N/A | N/A | 17.69% | 424.53 | 3.13 | 0.23 | Very High |
| Tata India Pharma & Healthcare Fund - Regular Plan - Growth | -7.42% | -6.38% | 5.15% | 4.71% | -0.23% | 15.22% | 11.84% | 12.5% | 11% | 1,511.49 | 2.37 | 0.23 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.62% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 6.15% |
| NET CURRENT ASSETS | Cash & Cash Equivalents and Net Assets | 5.85% | |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.24% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.81% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.06% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.70% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 3.03% |
| Caplin Point Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.02% |
| Global Health Ltd. | Healthcare Services | Domestic Equities | 2.96% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.89% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.81% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 2.80% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.79% |
| Marksans Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.25% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 2.21% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.12% |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | Domestic Equities | 2.09% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.07% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 2.02% |
| Procter & Gamble Health Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.95% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.80% |
| Aster DM Quality Care Ltd. | Healthcare Services | Domestic Equities | 1.76% |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 1.67% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.62% |
| Metropolis Healthcare Ltd. | Healthcare Services | Domestic Equities | 1.47% |
| Windlas Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.42% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.41% |
| Blue Jet Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.41% |
| Alembic Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.40% |
| Viyash Scientific Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.39% |
| Vijaya Diagnostic Centre Ltd. | Healthcare Services | Domestic Equities | 1.33% |
| Sudeep Pharma Ltd. | Chemicals & Petrochemicals | Domestic Equities | 1.28% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.26% |
| Eris Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.13% |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 1.08% |
| Manipal Health Enterprises Ltd. | Healthcare Services | Domestic Equities | 1.05% |
| Aarti Pharmalabs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.00% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.93% |
| Orchid Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.71% |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.67% |
| Jubilant Pharmova Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.65% |
| Indegene Ltd. | Healthcare Services | Domestic Equities | 0.50% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 0.42% |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.20% |
| CLEARING CORPORATION OF INDIA LTD. STD - MARGIN | Deposits (Placed as Margin) | 0.02% | |
| Total | 100.00% | ||
Mr. Gada is the Vice President - Equity. He has completed CA from ICAI and has cleared Level 3 of CFA from CFA Institute, USA. He graduated in Bachelor of Commerce in 2003 from Mumbai University. He began his career with PCL as Senior Accounts Officer in 2004. Kamal joined UTI AMC in 2008 as Research Analyst. He has over 16 years of experience in Equity Research. Presently he is Fund Manager for Scheme(s) of UTI Mutual Fund.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
